| Cas No.: | 1194506-26-7 |
| 名称: | |
| 别名: | Fruquintinib (HMPL-013) |
| SMILES: | CC1=C(C2=C(O1)C=C(C=C2)OC3=NC=NC4=CC(=C(C=C43)OC)OC)C(=O)NC |
| 分子式: | C21H19N3O5 |
| 分子量: | 393.13 |
| 纯度: | |
| 保存条件: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
| Description: | |
| In Vivo: | |
| In Vitro: | |
| References: | Fruquintinib, also known as HMPL-013, is an orally available, small molecule inhibitor of vascular endothelial growth factor receptors (VEGFRs), with potential anti-angiogenic and antineoplastic activities. Upon oral administration, fruquintinib inhibits |
| Kinase Assay: | |
| Cell Assay: | |
| Animal Administration: | |
| References: |

%20structure.gif)


